<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="rmv2054-fig-0003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Tactics for herpes simplex virus (HSV) vaccine development. The design of HSV vaccine candidates would be required to achieve at least six objectives including viral replication cycle mimicry, appropriation of the host immune response, lowest infectivity possible in immune cells, limited interference with host apoptosis, lowest possible or no pathological effect, and lowest possible or no neurotropic infectivity</p>
 </caption>
 <graphic id="nlm-graphic-5" xlink:href="RMV-29-na-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
